AIM: In order to assess hepatocellular carcinoma associated antigen HCA587 as a potential target for immunotherapy, the Bac-to-Bac expression system was used to express recombinant protein HCA587 in insect cells. METHODS: The cDNA encoding HCA587 gene was cloned into donor vector pFasBacHtb and recombinant pFasBac Htb-587 was transformed into competent cells DH10Bac. Recombinant Bacmid-587 was transfected into Sf9 insect cells using CELLFECTIN, Recombinant HCA587 protein was produced in Sf9 insect cells after infection with recombinant baculovirus, and was purified using Ni-NTA resin. Sera from HCC patients were also screened using recombinant protein HCA587. RESULTS: The molecular weight of the recombinant protein HCA587 expressed in insect cells was approximately 43kd. Western blot results proved the recombinant protein HCA587 had the similar antigenicity with its native counterpart. Serological analysis told that the rate of seroreactivity to HCA587 was not high in HCC patients. CONCLUSION: The recombinant protein HCA587 was successfully expressed and purified using Bac-to-Bac expression system. It paved the way for generation of specific antibody and investigation of immunohistochemical analysis and immune responses of HCC in the future.
AIM: In order to assess hepatocellular carcinoma associated antigen HCA587 as a potential target for immunotherapy, the Bac-to-Bac expression system was used to express recombinant protein HCA587 in insect cells. METHODS: The cDNA encoding HCA587 gene was cloned into donor vector pFasBacHtb and recombinant pFasBac Htb-587 was transformed into competent cells DH10Bac. Recombinant Bacmid-587 was transfected into Sf9 insect cells using CELLFECTIN, Recombinant HCA587 protein was produced in Sf9 insect cells after infection with recombinant baculovirus, and was purified using Ni-NTA resin. Sera from HCC patients were also screened using recombinant protein HCA587. RESULTS: The molecular weight of the recombinant protein HCA587 expressed in insect cells was approximately 43kd. Western blot results proved the recombinant protein HCA587 had the similar antigenicity with its native counterpart. Serological analysis told that the rate of seroreactivity to HCA587 was not high in HCC patients. CONCLUSION: The recombinant protein HCA587 was successfully expressed and purified using Bac-to-Bac expression system. It paved the way for generation of specific antibody and investigation of immunohistochemical analysis and immune responses of HCC in the future.
Authors: M Oiso; M Eura; F Katsura; M Takiguchi; Y Sobao; K Masuyama; M Nakashima; K Itoh; T Ishikawa Journal: Int J Cancer Date: 1999-05-05 Impact factor: 7.396
Authors: M Schmidt; A K Olejnik; K Stepień; A M Olejnik; W Butowska; W Grajek; J B Warchoł; A Gozdzicka-Józefiak Journal: Folia Histochem Cytobiol Date: 2001 Impact factor: 1.698
Authors: Matthew J Scanlan; Claudia M Gordon; Barbara Williamson; Sang-Yull Lee; Yao-Tseng Chen; Elisabeth Stockert; Achim Jungbluth; Gerd Ritter; Dirk Jäger; Elke Jäger; Alexander Knuth; Lloyd J Old Journal: Int J Cancer Date: 2002-04-01 Impact factor: 7.396
Authors: M E Perico; D Mezzanzanica; E Luison; P Alberti; L Panza; G Russo; S Canevari Journal: Cancer Immunol Immunother Date: 2000-08 Impact factor: 6.968
Authors: Albert J W Zendman; Annemieke A van Kraats; Anneke I den Hollander; Ulrich H Weidle; Dirk J Ruiter; Goos N P van Muijen Journal: Int J Cancer Date: 2002-01-10 Impact factor: 7.396
Authors: E Stockert; E Jäger; Y T Chen; M J Scanlan; I Gout; J Karbach; M Arand; A Knuth; L J Old Journal: J Exp Med Date: 1998-04-20 Impact factor: 14.307
Authors: Erwin S Schultz; Jacques Chapiro; Christophe Lurquin; Stéphane Claverol; Odile Burlet-Schiltz; Guy Warnier; Vincenzo Russo; Sandra Morel; Frédéric Lévy; Thierry Boon; Benoît J Van den Eynde; Pierre van der Bruggen Journal: J Exp Med Date: 2002-02-18 Impact factor: 14.307